课题基金 / 基金详情

Impact of chronic hepatitis C virus (HCV) direct-acting antiviral therapy on extrahepatic manifestations among HIV co-infected British Columbians engaged in clinical care

Impact of chronic hepatitis C virus (HCV) direct-acting antiviral therapy on extrahepatic manifestations among HIV co-infected British Columbians engaged in clinical care
慢性丙型肝炎病毒 (HCV) 直接抗病毒治疗对从事临床护理的 HIV 合并感染不列颠哥伦比亚省人肝外表现的影响
批准号：
391545
负责人：
Rossi Carmine
金额：
$0.05万
依托单位：
B.C. Centre for Disease Control (Vancouver)
依托单位国家：
加拿大
项目类别：
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-08-01 至 2019-08-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=391545&lang=en
关键词：
Ics Travel Awards

项目摘要

项目成果

Rossi Carmine的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Given similar acquisition risk factors, hepatitis C virus (HCV) co-infection is common among people living with HIV. With increasing life expectancy and reduced mortality from AIDS-related illnesses, HCV and its long-term sequalae, such as liver disease,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Real-world effectiveness of direct-acting antiviral therapy for chronic hepatitis C among HIV co-infected Canadians receiving clinical care
Population-level impact of direct-acting antiviral (DAA) therapies for chronic hepatitis C on extrahepatic manifestations
Rates and Risk Factors for Hepatitis C Re-Infection or Late Relapse after Sustained Virologic Response to Treatment among HIV Co-Infected Canadians
Injection Cocaine Use and Renal Function Decline among Hepatitis C-HIV Co-Infected Canadians Receiving Clinical Care